South Africa sees release of first Vodafone mHealth Solutions publication

South Africa – (11.11.2011) – Vodafone mHealth Solutions, a global team that works with mobile communications for healthcare services, recently released a new Insights Guide, which is also available in South Africa.

The Insights Guide delivers insights into the acceptance of new mobile health services in the developed world. It focuses on one of the fundamental barriers to the adoption of mHealth: human behaviour, by covering four key areas: An overview of mHealth opportunity; Evaluating behaviour to marketed mHealth services; Adopting technology: understanding the challenges for healthcare professionals, and Understanding health psychology and the science of behaviour.

The Insights Guide is part of the Vodafone Health Debate series, launched by Vodafone – known as Vodacom in South Africa – which is a continuing commitment to thought leadership in healthcare. The guide is the first in a series of guides which examine some of the greatest barriers to the adoption of mHealth services. It is positioned to drive the Health Debate forward through fresh perspectives and insights into topical and pivotal themes in the emerging market for mobile health.

Head of Vodafone mHealth Solutions, Axel Nemetz, commented “Our aim is to provide some evidence-based stimulus that will encourage all those working in the different areas of healthcare to consider the innovation opportunities that are now available to them. We believe that real progress can only be initiated when all stakeholders look beyond traditional horizons and share ideas that challenge the status quo so that together we can identify new ways of addressing current issues.”

The mobile health initiative aims to improve healthcare outcomes and quality of life by giving patients and healthcare professionals increased flexibility and freedom, for example, by more effective remote monitoring of patients, the provision and exchange of health related information or improved stock management for pharmaceutical drugs.

To view the Insights Guide in full, click here. Furthermore, you can have your input in the debate on LinkedIn, by joining the group: The Health Debate.

Be Sociable, Share!